Urinary Tract Cancer Market - Global Industry Perspective, Comprehensive Analysis and Forecast 2015-2021

Report Code: ZMR-28 | Report Format : | Status : Upcoming |

Abstract

Cancer is the adverse disease caused due to abnormal cell growth with potential to spread or invade to all over the body. Urinary tract cancer is generally known as bladder cancer. Uncontrolled growth of cells in the urinary tract is said as bladder cancer. The bladder cancer is recognized from the most common symptoms that is presence of blood in urine. The urine tract cancer is mainly observed among smokers, generic population, workers in chemical industries and people with prolonged urine infections. Patient can be survived in the bladder cancer if identified at early stages.

The report provides a comprehensive view on the urinary tract cancer market we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the urinary tract cancer market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period.

Increasing consumption of cigarettes globally coupled with increasing sedentary lifestyle had increased the incidence of urinary tract cancer. Accomplishment from the government to generate awareness regarding the urinary tract cancer and advance modern medications drives the urinary tract cancer market. Lack of awareness in the developing countries may suppress the growth of urinary tract cancer market. Nevertheless, untapped techniques for treatment of urinary tract cancer are likely to open new opportunities for the urinary tract cancer market in the coming years.

Based on type the urinary tract cancer market can be segmented as squamous cell carcinoma, adenocarcinoma and urothelial carcinoma among others. Urothelial carcinoma is leading segment with 95% of incidence rate, globally. On basis of diagnostic techniques, the urinary tract cancer market is segmented into, cystoscopy, transurethral resection of tumor, imaging tests and urine analyses among others. Different treatments for the urinary tract cancer include chemotherapy, intravesical therapy, radiation therapy, and surgery.

North America and Europe dominated the urinary tract cancer market owing to high prevalence rate of urinary tract cancer, increasing healthcare expenditure and sophisticated healthcare sector. Asia Pacific is expected to experience fastest growth in the forecast period. Factors such as increasing awareness, growing healthcare sector and rising government support for research and development are the driving factors for the urinary tract cancer market in these region.

Shionogi & Co., Ltd., Medical Enzymes AG, Amgen Inc, Spectrum pharmaceuticals, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, IkerChem S.L., Kyowa Hakko Kirin Co., Ltd and Genzyme Corporation among others are some of the leading players for the urinary tract cancer market.

The report segments of the urinary tract cancer market into:

Urinary Tract Cancer Market: Type Segment Analysis

  • Squamous cell carcinoma
  • Adenocarcinoma
  • Urothelial carcinoma a
  • Other

Urinary Tract Cancer Market: Diagnostic Techniques Segment Analysis

  • Cystoscopy
  • Transurethral resection of tumor
  • Imaging tests
  • Urine analyses
  • Others

Urinary Tract Cancer Market: Treatment Segment Analysis

  • Chemotherapy
  • Intravesical therapy
  • Radiation therapy
  • Surgery

Urinary Tract Cancer Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East & Africa

Related Reports

Medical Foam Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1129 | Report Format:

Global Medical Foam Market: Overview Medical graded foam has specific antimicrobial substances present in it in order to reduce the risks of the spread of bacteria, germs, and diseases in the hospitals or other medical sectors by its property of resisting against the contaminants. The medical fo...Read More

Chromatography Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1112 | Report Format:

Global Chromatography Reagents Market: Overview Chromatography is a parting method utilized to separate solutes and components in the moving fluid stream via chromatographic reagents. Chromatography has several applications in chemical and biological fields. Chromatography method and its reagent...Read More

Antinuclear Antibody Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1085 | Report Format:

Global Antinuclear Antibody Test Market: Overview The antinuclear antibodies are autoantibodies that attach to the specific contents of the nucleus present in the cell. They are also known as antinuclear factor or ANF. The autoantibodies are produced in the human body against the foreign particl...Read More

Myocardial Infarction Treatment Market by Product type (Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, Antithrombotic agents, Beta-adrenergic blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin-Receptor blockers, Analgesics, Thrombolytics); Distribution channel (Hospitals, Hospital Pharmacies, Drug Stores and Online Drug Stores); and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Feb-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-1084 | Report Format:

The report covers forecast and analysis for the myocardial infarction treatment market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the myocardial infarct...Read More

In Vitro Diagnostics (IVD) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1065 | Report Format:

Global In Vitro Diagnostics (IVD) Market: Overview In-vitro diagnostics tests are the tests performed outside the body of a patient. It uses reagents, devices, calibrators, analytical instruments, and systems for examination, detection of diseases, and health condition. Global In Vitro Diagnos...Read More

Choose License Type:
Latest Published Reports

View All Published Reports